Tissue Microarray or tissue array or TMA are an ideal method for studying multiple human cancer / normal tissues in a single assay. TMA can be used to screen different tumor types, non-malignant tissues, and normal tissues and cells, to rapidly assess the clinical significance of molecular alterations in cancer and other diseases. Tissue microarrays aid in the analysis of tumors from patients at different stages of disease development to identify gene alteration and frequency / tumor expression of molecular markers.
Tissue microarrays allow simultaneous analysis of hundreds of tissue samples on one microscope slide in the same amount of time that was previously required for a single specimen. Tissue microarrays increase throughput, conserve precious tissue resources, improve internal experimental controls, and reduce reagent consumption.
US Biolab provides a wide variety of formalin-fixed, paraffine-embedded (FFPE) tissue arrays and tissue microarrays. Based on the availability of more than 500,000 human samples in our tissue biorepository, we have constructed more than 5000 types of high quality tissue arrays to satisfy customers’ needs.
To inquire about the current availability of TMAs or to investigate your custom tissue array, send us an inquiry via form or email or call us at 301-417-4343.
- Please note that our tissue microarray has fresh-cut and pre-cut options and the fresh-cut option has a minimum order requirement.
- Custom TMA construction service available.
Please contact sni@usbiolab for more details.
TISSUE MICROARRAY (TMAS)
- Cat No.
- Description
- Total Cases
- Total Cores
- Price
- BRE0100-01A
- Breast cancer tumor tissue microarray with 17 Invasive ductal carcinoma cases, 25 invasive lobular carcinoma cases, 6 DCIS cases, and 2 normal cases (2 cores per case). Pathology grade, TNM classification, and Biomarker information (3 TNBC cases, 3 HR+, HER2- cases) available.
- 50
- 100
-
$280.00
- BRE024-01A
- Breast cancer tissue microarray. 1 core per case 10 invasive ductal carcinoma cases 10 invasive lobular carcinoma cases 2 DCIS cases, and 2 normal cases. (1 TNBC case/13 HR+, HER2- cases) available.
- 24
- 24
-
$60.00
- BRE048-01A
- Breast cancer tissue microarray - 2 cores per case 21 cases of invasive ductal carcinoma cases with matched normal adjacent tissue 1 case of mucinous carcinoma 2 cases of normal adjacent tissue (mostly HR+/HER- cases)
- 24
- 48
-
$170.00
- BRE110-01A
- Triple Negative Breast Cancer Tumor Tissue Microarray. 110 TNBC cases, and 1 normal tissue case. 1 core per case. - 25% or more cores missing/discounted
- 111
- 111
-
$200.00
- BRE110-01B
- Triple Negative Breast cancer tumor tissue microarray. 109 TNBC cases, 1 DCIS case, and 1 normal tissue. 1 core per case.
- 111
- 111
-
$400.00
- BRE120-01A
- Breast cancer tissue microarray - 1 core per case 111 TNBC cases, 5 HR+ HER2- cases, 2 DCIS cases, and 2 normal cases - 20% Cores missing/ 2 Precut slides left in inventory
- 120
- 120
-
$250.00
- HBre-Duc060CD-01
- Breast cancer tissue microarray. Tumor (1 core/case) and matched NAT (1 core/case). 100% cases have TNM detail informaion. Pathology grade 1, 2, 3. - 1 Pre Cut slide left
- 60
- 60
-
$235.00
- HBre-Duc140Sur-01
-
Breast cancer tissue microarray contains 140 cases of Invasive ductal carcinoma. Pathology grade, TNM Classification, Clinical Stage, Survival information availiable.
- 140
- 140
-
$1,485.00
- HBre-Duc140Sur-02
-
Breast carcinoma, 140 tumor cases (1 core/case) .Pathology grade, TNM, Clinical stage I, II, III (Version 6.0). Survival information available.
- 140
- 140
-
$1,485.00
- HBreD075Bc01
- Triple negative breast cancer tissue microarray 75 cases of IDC cases. Pathology grade, TNM Classification, and Stage information availiable. - 1 Pre cut slide left
- 75
- 75
-
$468.00
- HBreD090Bc01
-
Triple negative breast cancer tissue microarray with 90 IDC cases. Pathology grade, TNM, and Stage information availiable.
- 90
- 90
-
$468.00
- TMAFC1201
-
Breast Carcinoma Tissue Array with Survival and Treatment Info
- 26
- 84
-
$580.00
- TMAFC1202
-
Breast cancer tissue microarray 32 cases of breast carcinoma, HER2 negative. Pathology grade, TNM, Stage and follow up treatment information are available.
- 32
- 96
-
$580.00
- TMAFC1203
-
TNBC Tissue Microarray. 31 cases of triple-negative breast cancer, duplicate tumor and matched normal per case. B6&B7 are HER2+
- 31
- 96
-
$580.00